• Tackling Trial and Data Complexity in DCTs with Advanced Analytics and Machine Learning

    Sep 12 | Clinical Research News | Advanced statistical and machine learning (ML) models offer new ways to cope with an evolving and increasingly complex clinical trial data landscape. It enables us to interrogate new, complex and raw data sources, perform complex data reviews, learn from past studies and process large volumes of data. More

  • The Scope of Things: A Global Movement to Cure Multiple Myeloma

    Sep 10 | Clinical Research News | In this month’s episode of The Scope of Things podcast, Joseph Mikhael, chief medical officer of the International Myeloma Foundation (IMF), discusses how the Black Swan Research Initiative (BSRI), a global scientific alliance dedicated to finding a cure for multiple myeloma, and global collaborators are making strides in multiple myeloma research and prevention efforts. More

  • New Microbiome-Derived Proteins Trials for Chronic Disease Treatment

    Sep 09 | Clinical Research News | The gut microbiome has long been recognized as a key influencer of human health, but most clinical efforts to translate that knowledge have revolved around broad dietary interventions, probiotics, or microbial metabolites. Now, a team of researchers in Denmark is taking a new route that focuses on specific bacterial proteins that may directly regulate human metabolism and advancing them into clinical testing. More

  • LLMs Transform Clinical Trial Data Analysis with Human-Level Accuracy

    Sep 04 | Clinical Research News | A study presented at the American Association for Cancer Research (AACR) conference reveals that large language models (LLMs) can match human experts in identifying critical cancer progression events from electronic health records—a development with significant implications for clinical trials and personalized medicine. More

  • Many Trials Testing Psychedelics for Treating Substance Abuse Disorders

    Sep 02 | Clinical Research News | A resurgence of research interest in psychedelics over the past 25 years might soon see compounds like psilocybin, otherwise known as “magic mushrooms,” finally having their day. In the clinical trial setting, dozens of studies are now underway testing psychedelics for the treatment of post-traumatic stress disorder (PTSD), depression, and, perhaps most commonly, substance abuse disorders (SUDs). More

  • Study Cancellations Undercut Site Viability, Stakeholders Say

    Aug 28 | Clinical Research News | In an environment where clinical trial budgets are scrutinized and timelines compressed, the human and operational toll of cancelled studies poses a serious threat. It undercuts site stability, strains patient engagement, and jeopardizes future collaboration. A recent SCOPE 365 ClinEco Connect session convened industry veterans across sites, sponsors, and CROs to seek a solution. More

  • Follow the Money: Supplying Global Clinical Trials, Novel Next-Gen Biosensor, More

    Aug 27 | Clinical Research News | ARTBIO plans to rapidly advance its manufacturing network infrastructure to supply global clinical trials and commercialization, as well as their pipeline of alpha radioligand therapies; Sava Technologies will accelerate regulatory approval and commercialization of its next-generation wearable; and more. More

  • International Progressive MS Alliance Launches Data Platform, N-Power Launches Novel Platform, More

    Aug 26 | Clinical Research News | The International Progressive MS Alliance launched its MS Clinical and Imaging Data Resource (CIDR); N-Power Medicine announced the launch of the industry’s first Prospective External Control Arm (ProECA) platform; and more. More

  • Navigating the Complexities of Radiopharmaceutical Therapy Trials

    Aug 21 | Clinical Research News | Radiopharmaceutical therapy (RPT) has been around for a long time now, but advances in technology and understanding of the actionable molecular pathways that drive cancer have fueled a resurgence in interest and investment in the therapeutic modality. he popularity of RPTs is driven largely by theranostics combining diagnostic imaging and targeted therapy into a single, integrated system to more precisely deliver radiation to tumor cells and thereby minimize damage to healthy tissue. More

  • Non-Invasive Medical Devices Show Clinical Promise Across Multiple Indications

    Aug 19 | Clinical Research News | Clinical trials and preclinical studies are demonstrating the therapeutic potential of Openwater's infrared light and low-intensity focused ultrasound technologies across a diverse range of medical conditions, from cancer treatment to stroke diagnosis. More
View more articles
 
DXX-Industry-spotlight
SOT

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

Read More